{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:38:30Z","timestamp":1761745110084,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK82315"],"award-info":[{"award-number":["U01 DK82315"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>This study examined the prevalence of somatization disorder in Urological Chronic Pelvic Pain Syndrome (UCPPS) and the utility of two self-report symptom screening tools for assessment of somatization in patients with UCPPS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The study sample included 65 patients with UCPPS who enrolled in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Study at Washington University. Patients completed the PolySymptomatic PolySyndromic Questionnaire (PSPS-Q) (<jats:italic>n<\/jats:italic>\u2009=\u200964) and the Patient Health Questionnaire-15 Somatic Symptom Severity Scale (PHQ-15) (<jats:italic>n<\/jats:italic>\u2009=\u200950). Review of patient medical records found that only 47% (<jats:italic>n<\/jats:italic>\u2009=\u200930) contained sufficient documentation to assess Perley-Guze criteria for somatization disorder.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Few (only 6.5%) of the UCPPS sample met Perley-Guze criteria for definite somatization disorder. Perley-Guze somatization disorder was predicted by definite PSPS-Q somatization with at least 75% sensitivity and specificity. Perley-Guze somatization disorder was predicted by severe (&gt;\u200915) PHQ-15 threshold that had &gt;\u200990% sensitivity and specificity but was met by only 16% of patients. The moderate (&gt;\u200910) PHQ-15 threshold had higher sensitivity (100%) but lower specificity (52%) and was met by 52% of the sample.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The PHQ-15 is brief, but it measures symptoms constituting only one dimension of somatization. The PSPS-Q uniquely captures two conceptual dimensions inherent in the definition of somatization disorder, both number of symptoms and symptom distribution across multiple organ systems, with relevance for UCPPS as a syndrome that is not just a collection of urological symptoms but a broader syndrome with symptoms extending beyond the urological system.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12894-019-0556-3","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T11:04:07Z","timestamp":1575975847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Assessing somatization in urologic chronic pelvic pain syndrome"],"prefix":"10.1186","volume":"19","author":[{"given":"C. S.","family":"North","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. A.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. H.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. H.","family":"Alpers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"556_CR1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Text Revision edition","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Text Revision edition. Washington, DC: American Psychiatric Association; 2000."},{"key":"556_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual for Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.","edition":"5"},{"issue":"1","key":"556_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0022-3956(96)00051-9","volume":"31","author":"DJ Clauw","year":"1997","unstructured":"Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res. 1997;31(1):125\u201331.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"556_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.urology.2009.06.078","volume":"74","author":"JQ Clemens","year":"2009","unstructured":"Clemens JQ, Calhoun EA, Litwin MS, McNaughton-Collins M, Kusek JW, Crowley EM, Landis JR. Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology. 2009;74(5):983\u20137 quiz.","journal-title":"Urology"},{"key":"556_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2296-15-109","volume":"15","author":"M den Boeft","year":"2014","unstructured":"den Boeft M, van der Wouden JC, Rydell-Lexmond TR, de Wit NJ, van der Horst HE, Numans ME. Identifying patients with medically unexplained physical symptoms in electronic medical records in primary care: a validation study. BMC Fam Pract. 2014;15:109.","journal-title":"BMC Fam Pract"},{"issue":"2","key":"556_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0022-5347(05)65984-8","volume":"166","author":"DR Erickson","year":"2001","unstructured":"Erickson DR, Morgan KC, Ordille S, Keay SK, Xie SX. Nonbladder related symptoms in patients with interstitial cystitis. J Urol. 2001;166(2):557\u201361.","journal-title":"J Urol"},{"key":"556_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","volume":"26","author":"JP Feighner","year":"1972","unstructured":"Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Mu\u00f1oz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26:57\u201362.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"556_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0004867413484525","volume":"47","author":"A Frances","year":"2013","unstructured":"Frances A, Chapman S. DSM-5 somatic symptom disorder mislabels medical illness as mental disorder. Aust N Z J Psychiatry. 2013;47(5):483\u20134.","journal-title":"Aust N Z J Psychiatry"},{"issue":"16","key":"556_CR9","first-page":"279","volume":"112","author":"H Haller","year":"2015","unstructured":"Haller H, Cramer H, Lauche R, Dobos G. Somatoform disorders and medically unexplained symptoms in primary care. Dtsch Arztebl Int. 2015;112(16):279\u201387.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"556_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jpsychores.2013.09.005","volume":"75","author":"W Hauser","year":"2013","unstructured":"Hauser W, Wolfe F. The somatic symptom disorder in DSM 5 risks mislabelling people with major medical diseases as mentally ill. J Psychosom Res. 2013;75(6):586\u20137.","journal-title":"J Psychosom Res"},{"issue":"9","key":"556_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00127-006-0082-y","volume":"41","author":"W Hiller","year":"2006","unstructured":"Hiller W, Rief W, Brahler E. Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol. 2006;41(9):704\u201312.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"556_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-244X-13-91","volume":"13","author":"RD Kocalevent","year":"2013","unstructured":"Kocalevent RD, Hinz A, Brahler E. Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC Psychiatry. 2013;13:91.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"556_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","volume":"64","author":"K Kroenke","year":"2002","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258\u201366.","journal-title":"Psychosom Med"},{"issue":"4","key":"556_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","volume":"32","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Spitzer RL, Williams JB, Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345\u201359.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"556_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.juro.2017.03.132","volume":"198","author":"HH Lai","year":"2017","unstructured":"Lai HH, Jemielita T, Sutcliffe S, Bradley CS, Naliboff B, Williams DA, Gereau RW, Kreder K, Clemens JQ, Rodriguez LV, Krieger JN, Farrar JT, Robinson N, Landis JR. Characterization of whole body pain in urological chronic pelvic pain syndrome at baseline: a MAPP research network study. J Urol. 2017;198(3):622\u201331.","journal-title":"J Urol"},{"issue":"6","key":"556_CR16","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.juro.2013.12.031","volume":"191","author":"HH Lai","year":"2013","unstructured":"Lai HH, North CS, Andriole GL, Cupps L, Song D, Ness TJ, Hong BA. Urological symptoms in a subset of patients with urological chronic pelvic pain syndrome and a polysymptomatic, polysyndromic pattern of presentation. J Urol. 2013;191(6):1802\u20137.","journal-title":"J Urol"},{"issue":"6","key":"556_CR17","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.juro.2012.01.081","volume":"187","author":"HH Lai","year":"2012","unstructured":"Lai HH, North CS, Andriole GL, Sayuk GS, Hong BA. Polysymptomatic, polysyndromic presentation of patients with urological chronic pelvic pain syndrome. J Urol. 2012;187(6):2106\u201312.","journal-title":"J Urol"},{"key":"556_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2490-14-58","volume":"14","author":"JR Landis","year":"2014","unstructured":"Landis JR, Williams DA, Lucia MS, Clauw DJ, Naliboff BD, Robinson NA, van BA, Sutcliffe S, Schaeffer AJ, Rodriguez LV, Mayer EA, Lai HH, Krieger JN, Kreder KJ, Afari N, Andriole GL, Bradley CS, Griffith JW, Klumpp DJ, Hong BA, Lutgendorf SK, Buchwald D, Yang CC, Mackey S, Pontari MA, Hanno P, Kusek JW, Mullins C, Clemens JQ. The MAPP research network: design, patient characterization and operations. BMC Urol. 2014;14:58.","journal-title":"BMC Urol"},{"key":"556_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3928\/0048-5713-19880601-09","volume":"18","author":"RL Martin","year":"1988","unstructured":"Martin RL. Problems in the diagnosis of somatization disorder: effects on research and clinical practice. Psychiatr Ann. 1988;18:357\u201362.","journal-title":"Psychiatr Ann"},{"issue":"18","key":"556_CR20","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1001\/jama.1982.03320430063034","volume":"247","author":"GE Murphy","year":"1982","unstructured":"Murphy GE. The clinical management of hysteria. J Am Med Assoc. 1982;247(18):2559\u201364.","journal-title":"J Am Med Assoc"},{"key":"556_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/med\/9780190215460.003.0008","volume-title":"In Goodwin and Guze's psychiatric diagnosis","author":"CS North","year":"2018","unstructured":"North CS, Yutzy SH. Somatization disorder. In: In Goodwin and Guze's psychiatric diagnosis. 7th ed. Oxford: Oxford University Press; 2018. p. 207\u201326.","edition":"7"},{"issue":"5A Suppl","key":"556_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0090-4295(99)80333-1","volume":"49","author":"MP O'Leary","year":"1997","unstructured":"O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49(5A Suppl):58\u201363.","journal-title":"Urology"},{"issue":"9","key":"556_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJM196203012660901","volume":"266","author":"MJ Perley","year":"1962","unstructured":"Perley MJ, Guze SB. Hysteria--the stability and usefulness of clinical criteria. N Engl J Med. 1962;266(9):421\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"556_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jpsychores.2013.10.012","volume":"75","author":"W Rief","year":"2013","unstructured":"Rief W. A commentary on: somatic symptom disorder: an important change in DSM. J Psychosom Res. 2013;75(6):584.","journal-title":"J Psychosom Res"},{"issue":"3","key":"556_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1370\/afm.985","volume":"7","author":"H van Ravesteijn","year":"2009","unstructured":"van Ravesteijn H, Wittkampf K, Lucassen P, van de Lisdonk E, van den Hoogen H, van Weert H, Huijser J, Schene A, van Weel C, Speckens A. Detecting somatoform disorders in primary care with the PHQ-15. Ann Fam Med. 2009;7(3):232\u20138.","journal-title":"Ann Fam Med"},{"issue":"3","key":"556_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1017\/S2045796015000116","volume":"24","author":"JC Wakefield","year":"2015","unstructured":"Wakefield JC. DSM-5, psychiatric epidemiology and the false positives problem. Epidemiol Psychiatr Sci. 2015;24(3):188\u201396.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"556_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-clinpsy-032814-112800","volume":"12","author":"JC Wakefield","year":"2016","unstructured":"Wakefield JC. Diagnostic issues and controversies in DSM-5: return of the false positives problem. Annu Rev Clin Psychol. 2016;12:105\u201332.","journal-title":"Annu Rev Clin Psychol"},{"issue":"2","key":"556_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.rdc.2009.05.007","volume":"35","author":"DA Williams","year":"2009","unstructured":"Williams DA, Schilling S. Advances in the assessment of fibromyalgia. Rheum Dis Clin N Am. 2009;35(2):339\u201357.","journal-title":"Rheum Dis Clin N Am"},{"issue":"514","key":"556_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1192\/bjp.114.514.1115","volume":"114","author":"R Woodruff","year":"1968","unstructured":"Woodruff R. Hysteria: an evaluation of objective diagnostic criteria by the study of women with chronic medical illness. Br J Psychiatry. 1968;114(514):1115\u20139.","journal-title":"Br J Psychiatry"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-019-0556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12894-019-0556-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-019-0556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T01:15:35Z","timestamp":1607476535000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-019-0556-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1186\/s12894-019-0556-3","relation":{},"ISSN":["1471-2490"],"issn-type":[{"type":"electronic","value":"1471-2490"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"9 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for this study was obtained from the Institutional Review Board of Washington University, and written informed consent was provided by all patients at the time of their enrollment into the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (no individually identifying data are included).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}